Oppenheimer Asset Management Inc. Has $3.23 Million Holdings in CME Group Inc. (NASDAQ:CME)

Oppenheimer Asset Management Inc. cut its position in CME Group Inc. (NASDAQ:CME) by 55.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,618 shares of the financial services provider’s stock after selling 17,913 shares during the period. Oppenheimer Asset Management Inc.’s holdings in CME Group were worth $3,225,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. Capital International Investors raised its holdings in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after acquiring an additional 3,069,806 shares during the period. PineStone Asset Management Inc. increased its holdings in CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in shares of CME Group by 577.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after purchasing an additional 550,133 shares during the period. Ameriprise Financial Inc. lifted its holdings in shares of CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. Finally, International Assets Investment Management LLC boosted its position in shares of CME Group by 21,465.5% during the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after buying an additional 483,618 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have commented on CME. Deutsche Bank Aktiengesellschaft cut their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Keefe, Bruyette & Woods upped their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Morgan Stanley boosted their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research report on Tuesday, October 8th. Finally, Oppenheimer boosted their target price on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $224.47.

CME Group Price Performance

Shares of CME opened at $225.28 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market cap of $81.12 billion, a PE ratio of 23.69, a PEG ratio of 5.26 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36. The business has a 50-day simple moving average of $222.52 and a two-hundred day simple moving average of $210.26.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the firm posted $2.25 EPS. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. Analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is presently 48.37%.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.